Free Trial
NASDAQ:RMTI

Rockwell Medical (RMTI) Stock Price, News & Analysis

Rockwell Medical logo
$1.73 -0.10 (-5.46%)
Closing price 09/3/2025 04:00 PM Eastern
Extended Trading
$1.84 +0.11 (+6.36%)
As of 09/3/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Rockwell Medical Stock (NASDAQ:RMTI)

Key Stats

Today's Range
$1.66
$1.88
50-Day Range
$0.79
$1.83
52-Week Range
$0.78
$5.15
Volume
3.92 million shs
Average Volume
1.74 million shs
Market Capitalization
$59.56 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$4.00
Consensus Rating
Buy

Company Overview

Rockwell Medical Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
77th Percentile Overall Score

RMTI MarketRank™: 

Rockwell Medical scored higher than 77% of companies evaluated by MarketBeat, and ranked 233rd out of 938 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Rockwell Medical has received a consensus rating of Buy. The company's average rating score is 3.33, and is based on 2 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Rockwell Medical has received no research coverage in the past 90 days.

  • Read more about Rockwell Medical's stock forecast and price target.
  • Earnings Growth

    Earnings for Rockwell Medical are expected to decrease in the coming year, from $0.03 to ($0.03) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Rockwell Medical is -28.83, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Rockwell Medical is -28.83, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Rockwell Medical has a P/B Ratio of 1.97. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Rockwell Medical's valuation and earnings.
  • Percentage of Shares Shorted

    0.61% of the float of Rockwell Medical has been sold short.
  • Short Interest Ratio / Days to Cover

    Rockwell Medical has a short interest ratio ("days to cover") of 0.4, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Rockwell Medical has recently increased by 72.17%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Rockwell Medical does not currently pay a dividend.

  • Dividend Growth

    Rockwell Medical does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.61% of the float of Rockwell Medical has been sold short.
  • Short Interest Ratio / Days to Cover

    Rockwell Medical has a short interest ratio ("days to cover") of 0.4, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Rockwell Medical has recently increased by 72.17%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Rockwell Medical has a news sentiment score of 0.38. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.94 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for Rockwell Medical this week, compared to 2 articles on an average week.
  • Search Interest

    7 people have searched for RMTI on MarketBeat in the last 30 days. This is an increase of 40% compared to the previous 30 days.
  • MarketBeat Follows

    Only 1 people have added Rockwell Medical to their MarketBeat watchlist in the last 30 days. This is a decrease of -50% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Rockwell Medical insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $8,758.00 in company stock.

  • Percentage Held by Insiders

    Only 1.90% of the stock of Rockwell Medical is held by insiders.

  • Percentage Held by Institutions

    Only 23.31% of the stock of Rockwell Medical is held by institutions.

  • Read more about Rockwell Medical's insider trading history.
Receive RMTI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Rockwell Medical and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

RMTI Stock News Headlines

Trump’s betrayal exposed
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.tc pixel
See More Headlines

RMTI Stock Analysis - Frequently Asked Questions

Rockwell Medical's stock was trading at $2.04 on January 1st, 2025. Since then, RMTI stock has decreased by 15.2% and is now trading at $1.73.

Rockwell Medical, Inc. (NASDAQ:RMTI) announced its quarterly earnings results on Thursday, August, 14th. The company reported ($0.05) earnings per share for the quarter, meeting analysts' consensus estimates of ($0.05). The firm earned $16.07 million during the quarter, compared to analyst estimates of $16.33 million. Rockwell Medical had a negative trailing twelve-month return on equity of 6.79% and a negative net margin of 2.38%.
Read the conference call transcript
.

Rockwell Medical shares reverse split before market open on Friday, May 13th 2022.The 1-11 reverse split was announced on Friday, May 13th 2022. The number of shares owned by shareholders was adjusted after the closing bell on Friday, May 13th 2022. An investor that had 100 shares of stock prior to the reverse split would have 9 shares after the split.

Top institutional shareholders of Rockwell Medical include Armistice Capital LLC (6.29%), Globeflex Capital L P (0.91%), Marshall Wace LLP (0.51%) and Panagora Asset Management Inc. (0.14%). Insiders that own company stock include Larson Family Inve Irrevocable, Mark Strobeck, Timothy Chole, Jesse Neri and Mark H Ravich.
View institutional ownership trends
.

Shares of RMTI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Rockwell Medical investors own include NVIDIA (NVDA), Super Micro Computer (SMCI), Axcelis Technologies (ACLS), Opera (OPRA), ADMA Biologics (ADMA), ASML (ASML) and InterDigital (IDCC).

Company Calendar

Last Earnings
8/14/2025
Today
9/03/2025
Next Earnings (Estimated)
11/11/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED PRODUCTS
Sub-Industry
Health Care Equipment
Current Symbol
NASDAQ:RMTI
CIK
1041024
Employees
300
Year Founded
1995

Price Target and Rating

High Price Target
$5.00
Low Price Target
$3.00
Potential Upside/Downside
+131.2%
Consensus Rating
Buy
Rating Score (0-4)
3.33
Research Coverage
3 Analysts

Profitability

EPS (Trailing Twelve Months)
($0.06)
Trailing P/E Ratio
N/A
Forward P/E Ratio
57.67
P/E Growth
N/A
Net Income
-$480 thousand
Net Margins
-2.38%
Pretax Margin
-2.39%
Return on Equity
-6.79%
Return on Assets
-3.77%

Debt

Debt-to-Equity Ratio
0.30
Current Ratio
2.89
Quick Ratio
2.51

Sales & Book Value

Annual Sales
$101.49 million
Price / Sales
0.59
Cash Flow
$0.13 per share
Price / Cash Flow
13.52
Book Value
$0.88 per share
Price / Book
1.97

Miscellaneous

Outstanding Shares
34,430,000
Free Float
33,776,000
Market Cap
$59.56 million
Optionable
Optionable
Beta
1.83

Social Links

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (NASDAQ:RMTI) was last updated on 9/4/2025 by MarketBeat.com Staff
From Our Partners